Literature DB >> 21220758

The effect of decreasing renal function on lipoprotein profiles.

Per-Ola Attman1, Ola Samuelsson, Petar Alaupovic.   

Abstract

BACKGROUND: Progressive chronic kidney disease (CKD) is accompanied by dyslipidemia that is characterized by increased concentrations of intact and partially metabolized ApoB and ApoC-III-containing triglyceride-rich lipoproteins in very low-density lipoprotein, intermediate density lipoprotein (IDL) and low-density lipoprotein. The purpose of the present study was to characterize the distribution of individual discrete lipoprotein subclasses in relation to the glomerular filtration rate (GFR) in nondiabetic CKD subjects.
METHODS: Fifty-one subjects (33 patients with CKD and 18 asymptomatic subjects) with GFR ranging from 12 to 120 mL/min were studied. Individual ApoA- and ApoB-containing lipoprotein subclasses (Lp) were determined in plasma by sequential immunoaffinity chromatography and subsequent determination of apolipoprotein composition by electroimmunoassays. GFR was measured as plasma clearance of iohexol or (51)Cr-ethylenediaminetetraacetic acid.
RESULTS: There were no changes in concentrations of ApoA-containing lipoproteins with decreasing GFR. The levels of ApoB-containing lipoproteins increased significantly with decreasing GFR. There was a moderate increase of cholesterol-rich LpB and a 3-fold increase of ApoB- and ApoC-III-containing lipoproteins in subjects in the two lowest quintiles of GFR. This was accompanied by a significant increase of plasma ApoC-III.
CONCLUSIONS: Reduced renal function is associated with a complex alteration of the lipoprotein profile that is predominantly characterized by increased concentrations of triglyceride-rich lipoprotein subclasses containing both ApoB and ApoC-III.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21220758     DOI: 10.1093/ndt/gfq762

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  10 in total

1.  Vascular risk factors in INPH: A prospective case-control study (the INPH-CRasH study).

Authors:  Hanna Israelsson; Bo Carlberg; Carsten Wikkelsö; Katarina Laurell; Babar Kahlon; Göran Leijon; Anders Eklund; Jan Malm
Journal:  Neurology       Date:  2017-01-06       Impact factor: 9.910

Review 2.  Emerging Targets for Cardiovascular Disease Prevention in Diabetes.

Authors:  Nathan O Stitziel; Jenny E Kanter; Karin E Bornfeldt
Journal:  Trends Mol Med       Date:  2020-05-15       Impact factor: 11.951

3.  Revisiting secondary amyloidosis for an inadequately investigated feature: dyslipidemia.

Authors:  Serhan Piskinpasa; Hadim Akoglu; Eyup Koc; Fatma Dogru; Ezgi Yenigun Coskun; Didem Turgut; Nihal Ozkayar; Ramazan Ozturk; Ali Riza Odabas; Fatih Dede
Journal:  Rheumatol Int       Date:  2012-07-31       Impact factor: 2.631

4.  High-sensitivity C-reactive protein, apolipoproteins, and residual diuresis in chronic kidney disease patients undergoing hemodialysis.

Authors:  Daniela Lemos Borges; Helton Pereira Lemes; Valéria de Castro Ferreira; Sebastião Rodrigues Ferreira Filho
Journal:  Clin Exp Nephrol       Date:  2016-01-14       Impact factor: 2.801

5.  Apolipoprotein-defined lipoprotein subclasses, serum apolipoproteins, and carotid intima-media thickness in T1D.

Authors:  Arpita Basu; Alicia J Jenkins; Julie A Stoner; Ying Zhang; Richard L Klein; Maria F Lopes-Virella; W Timothy Garvey; David S Schade; Jamie Wood; Petar Alaupovic; Timothy J Lyons
Journal:  J Lipid Res       Date:  2018-03-25       Impact factor: 5.922

6.  Oxidative stress and inflammation in renal patients and healthy subjects.

Authors:  Diana M Lee; Kenneth W Jackson; Nicholas Knowlton; Joshua Wages; Petar Alaupovic; Ola Samuelsson; Aso Saeed; Michael Centola; Per-Ola Attman
Journal:  PLoS One       Date:  2011-07-28       Impact factor: 3.240

7.  Thyroid dysfunction and dyslipidemia in chronic kidney disease patients.

Authors:  Saroj Khatiwada; K C Rajendra; Sharad Gautam; Madhab Lamsal; Nirmal Baral
Journal:  BMC Endocr Disord       Date:  2015-10-29       Impact factor: 2.763

Review 8.  Uremic toxins and lipases in haemodialysis: a process of repeated metabolic starvation.

Authors:  Bernd Stegmayr
Journal:  Toxins (Basel)       Date:  2014-04-30       Impact factor: 4.546

9.  Grape seed powder improves renal failure of chronic kidney disease patients.

Authors:  Khaoula Turki; Kamel Charradi; Habib Boukhalfa; Monia Belhaj; Ferid Limam; Ezzedine Aouani
Journal:  EXCLI J       Date:  2016-06-27       Impact factor: 4.068

10.  Plasma lipoprotein(a) levels are associated with mild renal impairment in type 2 diabetics independent of albuminuria.

Authors:  Jennie Lin; Muredach P Reilly; Karen Terembula; F Perry Wilson
Journal:  PLoS One       Date:  2014-12-09       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.